ICD-9-CM Volume 2 Index entries containing back-references to
286.53:
- Antibody
anticardiolipin 795.79

with

hemorrhagic disorder 286.53

hypercoagulable state 289.81
antiphosphatidylglycerol 795.79

with

hemorrhagic disorder 286.53

hypercoagulable state 289.81
antiphosphatidylinositol 795.79

with

hemorrhagic disorder 286.53

hypercoagulable state 289.81
antiphosphatidylserine 795.79

with

hemorrhagic disorder 286.53

hypercoagulable state 289.81
antiphospholipid 795.79

with

hemorrhagic disorder 286.53

hypercoagulable state 289.81
- Anticoagulant
lupus (LAC) 795.79

with

hemorrhagic disorder 286.53

hypercoagulable state 289.81
- Circulating anticoagulants, antibodies, or inhibitors (see also Anticoagulants) 286.59

intrinsic, causing hemorrhagic disorder 286.59

with

acquired hemophilia 286.52


antiphospholipid antibody 286.53
- Disorder - see also Disease
hemorrhagic NEC 287.9

due to intrinsic circulating anticoagulants, antibodies, or inhibitors 286.59


with


acquired hemophilia 286.52



antiphospholipid antibody 286.53

specified type NEC 287.8
- Hemorrhage, hemorrhagic (nontraumatic) 459.0

disorder 287.9

due to intrinsic circulating anticoagulants, antibodies, or inhibitors 286.59


with


acquired hemophilia 286.52



antiphospholipid antibody 286.53

specified type NEC 287.8
due to
any device, implant, or graft (presence of) classifiable to 996.0
-996.5
- see Complications, due to (presence of) any device, implant, or graft classified to 996.0
-996.5
NEC
intrinsic circulating anticoagulant, antibodies, or inhibitors 286.59


with


acquired hemophilia 286.52



antiphospholipid antibody 286.53
- Inhibitor
systemic lupus erythematosus (presence of) 795.79

with

hemorrhagic disorder 286.53

hypercoagulable state 289.81
- Lupus 710.0

anticoagulant 795.79

with

hemorrhagic disorder 286.53

hypercoagulable state 289.81